← Leaderboards
Elizabeth H Nardin
New York University School Of Medicine
$7,927,613
Attributed
$8,423,565
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $909.7K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$8,423,565 · 4
By mechanism
R01$7,578,565 · 3
R56$845,000 · 1
Top collaborators
- Ute Frevert2 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Photini Sinnis$7,914,418
- Moriya Tsuji$11,242,468
- Victor Nussenzweig$5,382,044
- Fidel P Zavala$7,901,692
- Ana Rodriguez$8,975,691
Others in their field
Top investigators on “Malaria Vaccines”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$78,840,590
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
Malaria VaccinesMalariaCircumsporozoite ProteinPlasmodiumVaccine DevelopmentBaseVaccinesImmunizationPathogenImmune ResponseParasitesErythrocytesPlasmodium FalciparumSporozoitesCircumsporozoiteCellsStagingT-LymphocyteCellular ImmunityClinical TrialsImmunityLaboratory MouseAntibodiesSurface Antigens
Grant awards (20)
Development of a topical malaria vaccine.$658,790
R01 · FY2017 · AI · contact PI
Development of a topical malaria vaccine.$676,165
R01 · FY2016 · AI · contact PI
Development of a topical malaria vaccine.$495,942
R01 · FY2015 · AI · contact PI
Development of a topical malaria vaccine.$495,962
R01 · FY2014 · AI · contact PI
Malaria vaccines modified with TLR agonist adjuvant$422,500
R56 · FY2010 · AI · contact PI
Immunogenicity of Synthetic Peptide Malaria Vaccines$487,231
R01 · FY2009 · AI · contact PI
Malaria vaccines modified with TLR agonist adjuvant$422,500
R56 · FY2009 · AI · contact PI
Immunogenicity of Synthetic Peptide Malaria Vaccines$474,820
R01 · FY2008 · AI · contact PI
Immunogenicity of Synthetic Peptide Malaria Vaccines$476,477
R01 · FY2007 · AI · contact PI
T Cell Epitopes of the Malaria Circumsporozoite Proteins$320,485
R01 · FY2007 · AI · contact PI
Immunogenicity of Synthetic Peptide Malaria Vaccines$486,721
R01 · FY2006 · AI · contact PI
T Cell Epitopes of the Malaria CS Proteins$330,057
R01 · FY2006 · AI · contact PI
Immunogenicity of Synthetic Peptide Malaria Vaccines$438,138
R01 · FY2005 · AI
T Cell Epitopes of the Malaria CS Proteins$338,000
R01 · FY2005 · AI
T Cell Epitopes of the Malaria CS Proteins$330,065
R01 · FY2004 · AI
T Cell Epitopes of the Malaria CS Proteins$164,782
R01 · FY2003 · AI
IMMUNOGENICITY OF SYNTHETIC POLYOXIME MALARIA VACCINES$396,835
R01 · FY2002 · AI
IMMUNOGENICITY OF SYNTHETIC POLYOXIME MALARIA VACCINES$385,279
R01 · FY2001 · AI
IMMUNOGENICITY OF SYNTHETIC POLYOXIME MALARIA VACCINES$374,055
R01 · FY2000 · AI
T CELL EPITOPES OF THE MALARIA CS PROTEINS$248,761
R01 · FY2000 · AI